Liraglutide, sold under the brand names Victoza and Saxenda among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity... 31 KB (2,665 words) - 11:12, 1 May 2024 |
Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes... 7 KB (475 words) - 23:07, 17 April 2024 |
Danish scientist and university professor. She has led the development of liraglutide and semaglutide, two notable drugs against diabetes and obesity. Knudsen... 9 KB (771 words) - 22:13, 26 April 2024 |
dose compared to liraglutide in some of the measured parameters after ten weeks of daily intraperitoneal injections with liraglutide (2.5 or 25 nmol/kg)... 21 KB (1,918 words) - 15:23, 13 April 2024 |
blood. With the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are... 49 KB (5,099 words) - 06:09, 3 May 2024 |
S2CID 73313508. "Lilly's Once-Weekly Dulaglutide Shows Non-Inferiority to Liraglutide in Head-to-Head Phase III Trial for Type 2 Diabetes" (Press release)... 16 KB (1,512 words) - 06:23, 7 April 2024 |
(liraglutide) that is in the same class as exenatide. The data available for exenatide showed less of a risk towards thyroid cancer than liraglutide,... 24 KB (2,087 words) - 19:42, 15 April 2024 |